Lineage Cell Therapeutics Added 2024 Russell 3000 Index
Portfolio Pulse from Benzinga Newsdesk
Lineage Cell Therapeutics (LCTX) has been added to the 2024 Russell 3000 Index, effective July 1, 2024. This inclusion means automatic membership in either the Russell 1000 or Russell 2000 Index, as well as relevant growth and value style indexes.
July 02, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Lineage Cell Therapeutics (LCTX) has been added to the 2024 Russell 3000 Index, effective July 1, 2024. This inclusion means automatic membership in either the Russell 1000 or Russell 2000 Index, as well as relevant growth and value style indexes.
Inclusion in the Russell 3000 Index typically leads to increased visibility and potentially higher demand from institutional investors, which can positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100